Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

peptide receptor radionuclide therapy

(PEP-tide reh-SEP-ter RAY-dee-oh-NOO-klide THAYR-uh-pee)
A type of radiation therapy used to treat certain types of neuroendocrine tumors. A radioactive chemical is linked to a peptide (small protein) that targets cancer cells. When this radioactive peptide is injected into the body, it binds to a specific receptor found on some cancer cells. The radioactive peptide builds up in these cells and helps kill the cancer cells without harming normal cells. Peptide receptor radionuclide therapy is a type of targeted therapy. Also called PRRT.
Search NCI's Dictionary of Cancer Terms